Copertina

Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease

Alzheimer's Disease (AD) is characterized as a progressive neurodegenerative disease most commonly associated with memory deficits and cognitive decline. The formation of amyloid plaques and neurofibrillary tangles are important pathological markers of AD. The accumulation of amyloid plaques an...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Yasir Hasan Siddique (Autore), Falaq Naz (Autore), Rahul (Autore), Himanshi Varshney (Autore)
Natura:	Libro
Pubblicazione:	Elsevier, 2022-01-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Protective effect of luteolin on the transgenic Drosophila model of Parkinson's disease
di: Yasir Hasan Siddique, et al.
Pubblicazione: (2018)

Effect of Itrifal Muqawwi-e-Dimagh (a polyherbal drug) on the transgenic Drosophila model of Parkinson's Disease
di: Yasir Hasan Siddique, et al.
Pubblicazione: (2021)

Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease
di: Yasir Hasan Siddique, et al.
Pubblicazione: (2016)

QT interval prolongation and with donepezil, rivastigmine and galantamine
di: Katie Malone, et al.
Pubblicazione: (2020)

Effect of myricetin on the transgenic Drosophila model of Parkinsonâs disease
di: Gulshan Ara, et al.
Pubblicazione: (2017)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
di: Andreas Wentrup, et al.
Pubblicazione: (2008)

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer's disease
di: Faisal Imam, et al.
Pubblicazione: (2024)

New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease
di: Leo Bon, et al.
Pubblicazione: (2024)

Protective effect of Genistein against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in Swiss albino rats
di: Fahad Ali, et al.
Pubblicazione: (2015)

Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease
di: Mohd Adnan, et al.
Pubblicazione: (2023)

Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease
di: Yi Zhou, et al.
Pubblicazione: (2023)

Synaptic abnormalities in a Drosophila model of Alzheimer's disease
di: Siddhita D. Mhatre, et al.
Pubblicazione: (2014)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease
di: A. Claudio Cuello, et al.
Pubblicazione: (2019)

Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer's disease in Wistar rats
di: Manickam Rajkumar, et al.
Pubblicazione: (2022)

Hierarchical Porous Carbon-PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer's Disease Therapy
di: Stavroula G. Nanaki, et al.
Pubblicazione: (2020)

Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy
di: Dilyana Georgieva, et al.
Pubblicazione: (2023)

Galantamine ameliorates experimental pancreatitis
di: Dane A. Thompson, et al.
Pubblicazione: (2023)

Acquired Localized Hypertrichosis Induced by Rivastigmine
di: Adrian Imbernón-Moya, et al.
Pubblicazione: (2016)

Correction: Galantamine ameliorates experimental pancreatitis
di: Dane A. Thompson, et al.
Pubblicazione: (2024)

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
di: Yukio Ago, et al.
Pubblicazione: (2011)

Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer's Disease
di: Nianxin Kang, et al.
Pubblicazione: (2022)

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease
di: Giuseppe Caruso, et al.
Pubblicazione: (2021)

Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever
di: Ibrahim T. Mughrabi, et al.
Pubblicazione: (2022)

Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model
di: Tânia M. T. Guimarães, et al.
Pubblicazione: (2022)

The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease
di: Ko-Fan Chen, et al.
Pubblicazione: (2014)

Animal models for Alzheimer's disease: a focused review of transgenic rodent models and behavioral assessment methods
di: Xiaoli Wu, et al.
Pubblicazione: (2015)

Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease
di: Sha Liu, et al.
Pubblicazione: (2016)

DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes
di: Bangfu Zhu, et al.
Pubblicazione: (2022)

NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer's Disease
di: Paula Maria Quaglio Bellozi, et al.
Pubblicazione: (2019)

Preparation and evaluation of novel galantamine hydrobromide sustained-release capsule
di: Shuoye Yang
Pubblicazione: (2016)

Ameliorative effect of galantamine on acetic acid-induced colitis in rats
di: Niloofar-Sadat Mahdavi, et al.
Pubblicazione: (2019)

The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease
di: Soojin Lee, et al.
Pubblicazione: (2016)

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
di: Tahereh Jamshidnejad-Tosaramandani, et al.
Pubblicazione: (2021)

Effects of Rivastigmine and Donepezil on Brain Acetylcholine Levels in Acetylcholinesterase-Deficient Mice
di: Runa S. Naik, et al.
Pubblicazione: (2009)

Polygalae Radix Extract Prevents Axonal Degeneration and Memory Deficits in a Transgenic Mouse Model of Alzheimer's Disease
di: Tomoharu Kuboyama, et al.
Pubblicazione: (2017)

Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models
di: Stanislaw eMitew, et al.
Pubblicazione: (2013)

Cytotoxic activity of Galantamine hydrobromide against HeLa cell line
di: Danka Obreshkova, et al.
Pubblicazione: (2023)

Synergistic Effects of Galantamine and Memantine in Attenuating Scopolamine-Induced Amnesia in Mice
di: Perrine Busquet, et al.
Pubblicazione: (2012)

Determination of galantamine hydrobromide in bulk drug and pharmaceutical dosage form by spectrofluorimetry
di: Amit V Patel, et al.
Pubblicazione: (2013)

Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy
di: John David Eun, et al.
Pubblicazione: (2022)